Detection of tumour hypoxia: Comparison between EF5 adducts and [ 18F]EF3 uptake on an individual mouse tumour basis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 5, 2006, Pages 553-556

  Mahy, P ^a   De Bast, M ^a   Gillart, J ^a   Labar, D ^a   Gregoire V ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

18F EF3; EF5; Immunofluorescence; PET scan; Tumour hypoxia

Indexed keywords

2 (2 NITROIMIDAZOL 1 YL) N (3,3,3 TRIFLUOROPROPYL)ACETAMIDE F 18; 2 NITROIMIDAZOLE DERIVATIVE; CARBOGEN; FLUORINE 18; MONOCLONAL ANTIBODY; OXYGEN; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BREAST CARCINOMA; CONTROLLED STUDY; DRUG DISTRIBUTION; FIBROSARCOMA; HYPOXIA; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; OXYGEN TENSION; VALIDATION STUDY;

ANIMALS; CELL HYPOXIA; DRUG EVALUATION, PRECLINICAL; ETANIDAZOLE; FIBROSARCOMA; FLUORESCENT ANTIBODY TECHNIQUE; HYDROCARBONS, FLUORINATED; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C3H; NITROIMIDAZOLES; ORGAN SPECIFICITY; OXYGEN; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 33646399189     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0049-3     Document Type: Article

References (9)

1. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-276
2. 18F]EF3. Eur J Nuc Med Mol Imaging 2004;31:1263-1272
3. Koch CJ. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol 2002;352:3-31
4. Mahy P, De Bast M, Gallez B, Gueulette J, Koch CJ, Scalliet P, Grégoire V. In vivo colocalisation of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. Radiother Oncol 2003;67:53-61
5. 18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3- trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. Bioorg Med Chem 2001;9:665-675
6. Milas L, Hunter N, Mason K, Withers HR. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 1974;34:61-71
7. Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch CJ. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]. Br J Cancer 1995;72:875-882
8. Mahy P, Reychler H, Gueulette J, Scalliet P, Grégoire V. Immunofluorescence analysis of hypoxia in squamous cell carcinoma and fibrosarcoma murine tumors using a pentafluorinated nitroimidazole compound (EF5). J Cranio-Maxillofac Surg 1998;26:111
9. Rasey JS, Grunbaum Z, Magee S, Nelson NJ, Olive PL, Durand RE, Krohn KA. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res 1987;111:292-304